ProQR Therapeutics N.V. buy Cantor Fitzgerald
Start price
27.06.25
/
50%
€1.84
Target price
27.06.26
€6.84
Performance (%)
-28.44%
End price
28.06.26
€1.32
Summary
This prediction ended on 28.06.26 with a price of €1.32. The prediction for ProQR Therapeutics N.V. disappointed with a performance of -28.44%. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| ProQR Therapeutics N.V. | -4.202% | -4.202% | -19.237% |
| iShares Core DAX® | 0,85 % | 0,39 % | 2,53 % |
| iShares Nasdaq 100 | -0,99 % | -4,40 % | 25,15 % |
| iShares Nikkei 225® | -1,78 % | -11,22 % | 44,40 % |
| iShares S&P 500 | 0,06 % | 0,78 % | 20,95 % |
Comments by Cantor_Fitzgerald for this prediction
In the thread ProQR Therapeutics N.V. diskutieren
ProQR Therapeutics N.V. (NASDAQ: PRQR) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $8.00 price target on the stock.
Ratings data for PRQR provided by MarketBeat
In the thread Trading ProQR Therapeutics N.V.
Die von Cantor_Fitzgerald gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Cantor_Fitzgerald for ProQR Therapeutics N.V.
ProQR Therapeutics N.V.
Start price
Target price
Perf. (%)
€1.38
29.04.25
29.04.25
€7.02
29.04.26
29.04.26
-5.95%
30.04.26
30.04.26
